Dr. Burris is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
925 Campbell Ave
West Haven, CT 06516Phone+1 203-932-5711
Education & Training
Yale-New Haven Medical CenterResidency, Psychiatry, 2019 - 2023
Vanderbilt University School of MedicineClass of 2019, MD, Founder’s Medal, Beauchamp Prize in Psychiatry, Kaufman Prize in Medicine, American Medical Women’s Association Glasgow-Rubin Citation for Academic Achievement
University of VirginiaBA, Degree conferred with Honors, 2006 - 2010
Certifications & Licensure
CT State Medical License 2019 - 2025- American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- Founder's Medal Vanderbilt University, 2019
- Alpha Omega Alpha Honor Medical Society Vanderbilt University School of Medicine, 2018
- Gold Humanism Honor Society Vanderbilt University School of Medicine, 2017
Publications & Presentations
PubMed
- 1 citationsComparing Patient-Reported Outcomes Among Anti-TNF Experienced Patients With Ulcerative Colitis Initiating Vedolizumab Versus Tofacitinib.Michael D Kappelman, Millie D Long, Xian Zhang, Feng-Chang Lin, Laura Weisbein
Crohn's & Colitis 360. 2023-07-01 - 8 citationsReal-World Evidence Comparing Vedolizumab and Ustekinumab in Antitumor Necrosis Factor-Experienced Patients With Crohn's Disease.Michael D Kappelman, Sruthi Adimadhyam, Laura Hou, Audrey E Wolfe, Samantha Smith
The American Journal of Gastroenterology. 2023-04-01 - 9 citationsCrohn's and Colitis Foundation of America Partners Patient-Powered Research Network: Patient Perspectives on Facilitators and Barriers to Building an Impactful Patient...Arlene E. Chung, Maihan B. Vu, Kelly D. Myers, Jessica L. Burris, Michael D. Kappelman
Medical Care. 2018-10-01
Journal Articles
- Comparison of Outcomes, Adverse Events, and Treatment Burden of Intravenous Chemotherapy vs. Intra-arterial Chemotherapy for Retinoblastoma: Results of a Pilot StudyPranav Santapuram; Jessica Burris; Debra Friedman; Tatsuki Koyama; Anthony Daniels, Investigative Ophthalmology & Visual Science, 7/2019
Authored Content
- I Stayed so He Wouldn't Die Alone, but He Still DidMay 2019
- I Stayed so He Wouldn't Die Alone, but He Still DidMay 2019
- Patients and Researchers Join Forces to Fight Inflammatory Bowel DiseaseDecember 2015
- What I Want to Tell Patients as a Medical Student and Fellow PatientSeptember 2015
- Join now to see all
Press Mentions
Doximity’s 'Hindsight Is 2020' Writing Contest: Call for Submissions!October 3rd, 2020
First-Ever National Study of Dietary Interventions to Treat Crohn's Disease Receives FundingMarch 20th, 2020
CCFA receives $2.5 million for study of dietary interventions in Crohn’s diseaseMarch 20th, 2020- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
